当前位置:
X-MOL 学术
›
Cancer Cell
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Cytotoxic CD4+ T Cells in Bladder Cancer-A New License to Kill.
Cancer Cell ( IF 50.3 ) Pub Date : 2020-07-13 , DOI: 10.1016/j.ccell.2020.06.013 Adrian G Sacher 1 , Michael St Paul 1 , Christopher J Paige 1 , Pamela S Ohashi 1
中文翻译:
膀胱癌中的细胞毒性CD4 + T细胞-一种新的杀伤许可。
更新日期:2020-07-13
Cancer Cell ( IF 50.3 ) Pub Date : 2020-07-13 , DOI: 10.1016/j.ccell.2020.06.013 Adrian G Sacher 1 , Michael St Paul 1 , Christopher J Paige 1 , Pamela S Ohashi 1
Affiliation
CD4+ T cells with cytotoxic capability are increasingly recognized as potentially key actors in anti-tumor immunity. A new report in Cell elucidates the presence and potential role of a population of cytotoxic CD4+ T cells in bladder cancer using single cell sequencing technology.
中文翻译:
膀胱癌中的细胞毒性CD4 + T细胞-一种新的杀伤许可。
具有细胞毒性能力的CD4 + T细胞越来越被认为是抗肿瘤免疫力的潜在关键角色。Cell的一项新报告阐明了使用单细胞测序技术的细胞毒性CD4 + T细胞群在膀胱癌中的存在和潜在作用。